Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2024 = ×
Dec 31, 2023 = ×
Dec 31, 2022 = ×
Dec 31, 2021 = ×
Dec 31, 2020 = ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The analysis of the financial data over the specified years reveals some notable trends in profitability and capital structure metrics.

Return on Assets (ROA)
ROA demonstrated a generally stable performance between 2020 and 2023, with values fluctuating marginally between 7.81% and 8.19%. This stability suggests consistent asset efficiency in generating profits during this period. However, in 2024, there was a significant decline to 4.83%, indicating a substantial reduction in the company’s effectiveness in utilizing its assets to produce earnings.
Financial Leverage
The financial leverage ratio showed modest variability across the period. It began at 3.01 in 2020, slightly decreased to 2.96 in 2021, then increased to 3.16 in 2022. It remained relatively stable at 3.08 in 2023 before rising again to 3.22 in 2024. This gradual increase from 2021 onwards suggests a tendency to rely more on debt financing relative to equity, potentially increasing financial risk.
Return on Equity (ROE)
The ROE trend closely mirrored the ROA with growth from 23.52% in 2020 to a peak of 25.87% in 2022, followed by a slight decrease to 25.22% in 2023. The substantial decline to 15.55% in 2024 aligns with the drop in ROA, pointing to reduced profitability for shareholders. Despite variations in leverage, the decline in ROE was proportionally more pronounced than the change in leverage, indicating that profitability pressures rather than changes in capital structure primarily drove the decline.

In summary, the company maintained solid profitability and a stable capital structure from 2020 through 2023. However, in 2024, there was a marked downturn in returns on both assets and equity, accompanied by a modest increase in financial leverage. This shift suggests a potentially challenging operating environment impacting asset efficiency and shareholder returns, alongside a slightly higher reliance on financial debt.


Three-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2024 = × ×
Dec 31, 2023 = × ×
Dec 31, 2022 = × ×
Dec 31, 2021 = × ×
Dec 31, 2020 = × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


Net Profit Margin
The net profit margin showed a relatively stable pattern from 2020 through 2023, fluctuating modestly between 6.03% and 6.25%. However, in 2024, a significant decline occurred, with the margin dropping sharply to 3.65%, indicating a notable reduction in profitability relative to revenue.
Asset Turnover
The asset turnover ratio remained fairly consistent throughout the five-year period, ranging narrowly from 1.30 to 1.34. This suggests a stable efficiency in using assets to generate sales, with no substantial improvements or deteriorations observed.
Financial Leverage
Financial leverage exhibited slight fluctuations, starting at 3.01 in 2020, dropping marginally to 2.96 in 2021, then rising to 3.16 in 2022. Following a moderate decrease to 3.08 in 2023, it increased again to 3.22 in 2024. Overall, leverage levels remained relatively high, indicating consistent use of debt or other liabilities for financing.
Return on Equity (ROE)
ROE consistently improved from 23.52% in 2020 to a peak of 25.87% in 2022, reflecting efficient earnings generation on shareholders' equity. A slight decline to 25.22% occurred in 2023, followed by a marked drop to 15.55% in 2024, mirroring the decrease in net profit margin and suggesting diminished overall profitability in relation to equity invested.

Five-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2024 = × × × ×
Dec 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Dec 31, 2021 = × × × ×
Dec 31, 2020 = × × × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The financial analysis over the five-year period reveals several key trends in the company's performance and efficiency metrics. Overall, the company maintained a relatively stable tax burden with minor fluctuations, reflecting consistency in tax management or effective tax planning strategies. The tax burden ratio slightly increased from 0.76 in 2020 to around 0.79 during the middle years, before slightly decreasing to 0.75 in the latest period.

In terms of interest burden, there is a noticeable downward trend from 0.92 in 2020 to 0.83 in 2024. This decrease suggests an improvement in the company’s ability to manage interest expenses relative to earnings before interest and taxes, potentially indicating reduced interest costs or increased operating earnings.

The EBIT margin, which measures operating profitability, remained relatively stable between 8.25% and 8.67% from 2020 through 2023. However, there was a significant decline in 2024 to 5.86%, indicating reduced operational efficiency or increased operating expenses in the most recent year.

Asset turnover ratios remained fairly steady, hovering around the 1.3 mark throughout the five years. This stability suggests that the company’s effectiveness in utilizing its assets to generate revenue has been consistent without meaningful improvement or deterioration.

Financial leverage showed moderate variation, with a slight decrease at the start of the period followed by an upward trend, ending at 3.22 in 2024. This indicates an increased reliance on debt or other liabilities to finance the company’s assets, which could increase financial risk but may also enhance returns as long as earnings remain robust.

Return on equity (ROE) demonstrated growth from 23.52% in 2020 to a peak of 25.87% in 2022, followed by a slight decline in 2023 and a sharp drop to 15.55% in 2024. The initial increase in ROE alongside stable asset turnover and leverage suggests improving profitability and effective use of equity. The sharp fall in 2024 aligns with the reduced EBIT margin and may reflect operational challenges or other adverse financial conditions affecting overall profitability.

Tax Burden
Relatively stable with minor fluctuations, ending slightly lower in 2024.
Interest Burden
Consistent improvement over time, indicating better interest expense management.
EBIT Margin
Stable until 2023, then a significant decline in 2024, pointing to reduced operating profitability.
Asset Turnover
Steady utilization of assets in generating revenue without marked change.
Financial Leverage
Increasing leverage over time, suggesting higher financial risk but potential for enhanced returns.
Return on Equity (ROE)
Improved initially, followed by a sharp decline in 2024, largely influenced by decreased EBIT margin and other factors.

Two-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2024 = ×
Dec 31, 2023 = ×
Dec 31, 2022 = ×
Dec 31, 2021 = ×
Dec 31, 2020 = ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The financial data exhibits several notable trends in key performance indicators over the five-year period ending in 2024.

Net Profit Margin
The net profit margin showed a generally stable performance from 2020 through 2023, maintaining a range between 6.03% and 6.25%. However, in 2024, there is a significant decline to 3.65%, indicating a substantial reduction in profitability relative to revenue in that year. This sharp decrease suggests increased costs, lower revenue efficiency, or other adverse factors impacting the company's earnings.
Asset Turnover
The asset turnover ratio remained relatively stable across the entire period, fluctuating slightly between 1.3 and 1.34. This consistency suggests that the company has maintained a stable level of efficiency in utilizing its assets to generate revenue without significant improvement or deterioration.
Return on Assets (ROA)
Return on assets followed a similar pattern to net profit margin, with values holding steady around 7.8% to 8.2% from 2020 to 2023. In 2024, ROA dropped sharply to 4.83%, reflecting a considerable decrease in the company’s ability to generate profit from its asset base. This decline corresponds with the drop in net profit margin, highlighting weaker overall operational performance in the final year.

In summary, despite consistent operational efficiency as reflected by a stable asset turnover ratio, profitability metrics such as net profit margin and return on assets experienced a marked downturn in 2024. This suggests that factors other than asset utilization, such as increased expenses, diminished revenue, or other external influences, have negatively affected the company's financial outcomes.


Four-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2024 = × × ×
Dec 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Dec 31, 2021 = × × ×
Dec 31, 2020 = × × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The financial data over the five-year period reveals several key trends in the company's performance ratios and margins. Overall, the company exhibited relatively stable operational efficiency and profitability metrics until the most recent year, where some declines are evident.

Tax Burden
The tax burden ratio remained fairly consistent, fluctuating slightly between 0.75 and 0.79. The ratio was at its highest in 2021 and 2023 (0.79) and dropped to 0.75 in 2024, indicating a modest decrease in the proportion of earnings lost to taxes in the latest year.
Interest Burden
This ratio showed a gradual decline over the period, starting at 0.92 in 2020 and decreasing to 0.83 by 2024. This trend suggests that the company’s earnings before interest and taxes are becoming more heavily impacted by interest expenses, potentially reflecting higher debt levels or increased interest costs in the most recent years.
EBIT Margin
The EBIT margin was relatively stable around the 8.2% to 8.7% range for four consecutive years, reaching a peak of 8.67% in 2022. However, a significant decline to 5.86% was observed in 2024, indicating a notable reduction in operating profitability. This sharp drop merits further investigation to determine if it relates to increased costs, pricing pressure, or other operational challenges.
Asset Turnover
The asset turnover ratio remained consistent across the timeframe, hovering between 1.3 and 1.34. This stability indicates that the company’s efficiency in generating revenue from its asset base has been maintained without substantial improvement or deterioration.
Return on Assets (ROA)
ROA showed a generally stable upward trend from 7.81% in 2020 to a peak of 8.19% in 2022, indicating improving overall profitability relative to assets. However, in 2024, ROA declined sharply to 4.83%, mirroring the fall in EBIT margin and signaling potential issues in profitability and asset utilization in the latest year.

In summary, most key profitability metrics and burdens were stable or slightly improving until 2023, after which there was a pronounced decline in EBIT margin and ROA in 2024, accompanied by a decrease in interest burden ratio. The consistent asset turnover implies operational efficiency remained steady despite profitability challenges. These trends suggest emerging challenges that could warrant attention to maintain financial health and profitability going forward.


Disaggregation of Net Profit Margin

UnitedHealth Group Inc., decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2024 = × ×
Dec 31, 2023 = × ×
Dec 31, 2022 = × ×
Dec 31, 2021 = × ×
Dec 31, 2020 = × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The financial data reveals several notable trends over the five-year period.

Tax Burden
The tax burden ratio shows moderate fluctuations. It increased from 0.76 in 2020 to 0.79 in 2021, stayed stable at 0.78 in 2022, held steady again at 0.79 in 2023, then decreased to 0.75 in 2024. This indicates a generally stable tax environment with a slight easing in the most recent year.
Interest Burden
The interest burden ratio remained relatively steady around the low 0.90s from 2020 to 2023, starting at 0.92 in 2020 and peaking at 0.93 in 2021 and 2022. There was a noticeable decline to 0.90 in 2023 and a more significant drop to 0.83 in 2024. This suggests an improvement in interest cost management or reduced debt levels in the last year.
EBIT Margin
The EBIT margin remained relatively stable from 2020 through 2023, fluctuating narrowly between 8.25% and 8.67%, indicating consistent operational profitability. However, in 2024, there was a marked decline to 5.86%, signaling a sizable reduction in earnings before interest and taxes as a percentage of revenue.
Net Profit Margin
The net profit margin displayed a generally positive trend from 2020 to 2022, rising from 6.03% to 6.25%, with a slight dip to 6.09% in 2023. Thereafter, it decreased sharply to 3.65% in 2024. This sharp fall points to reduced bottom-line profitability despite relatively stable margins in prior years.

Overall, the data reflects stable tax and interest burdens in earlier years with improvements in interest burden by 2024. Profitability metrics such as EBIT margin and net profit margin remained steady before declining substantially in 2024, indicating possible challenges affecting net earnings and operating income in the latest year.